1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Metabolic Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Diabetes 1.2.3 Obesity 1.2.4 Hypercholesterolemia 1.2.5 Lysosomal storage diseases 1.3 Market by Application 1.3.1 Global Metabolic Syndrome Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Metabolic Syndrome Market Perspective (2016-2027) 2.2 Metabolic Syndrome Growth Trends by Regions 2.2.1 Metabolic Syndrome Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Metabolic Syndrome Historic Market Share by Regions (2016-2021) 2.2.3 Metabolic Syndrome Forecasted Market Size by Regions (2022-2027) 2.3 Metabolic Syndrome Industry Dynamic 2.3.1 Metabolic Syndrome Market Trends 2.3.2 Metabolic Syndrome Market Drivers 2.3.3 Metabolic Syndrome Market Challenges 2.3.4 Metabolic Syndrome Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Metabolic Syndrome Players by Revenue 3.1.1 Global Top Metabolic Syndrome Players by Revenue (2016-2021) 3.1.2 Global Metabolic Syndrome Revenue Market Share by Players (2016-2021) 3.2 Global Metabolic Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Metabolic Syndrome Revenue 3.4 Global Metabolic Syndrome Market Concentration Ratio 3.4.1 Global Metabolic Syndrome Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Metabolic Syndrome Revenue in 2020 3.5 Metabolic Syndrome Key Players Head office and Area Served 3.6 Key Players Metabolic Syndrome Product Solution and Service 3.7 Date of Enter into Metabolic Syndrome Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Metabolic Syndrome Breakdown Data by Type 4.1 Global Metabolic Syndrome Historic Market Size by Type (2016-2021) 4.2 Global Metabolic Syndrome Forecasted Market Size by Type (2022-2027) 5 Metabolic Syndrome Breakdown Data by Application 5.1 Global Metabolic Syndrome Historic Market Size by Application (2016-2021) 5.2 Global Metabolic Syndrome Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Metabolic Syndrome Market Size (2016-2027) 6.2 North America Metabolic Syndrome Market Size by Type 6.2.1 North America Metabolic Syndrome Market Size by Type (2016-2021) 6.2.2 North America Metabolic Syndrome Market Size by Type (2022-2027) 6.2.3 North America Metabolic Syndrome Market Size by Type (2016-2027) 6.3 North America Metabolic Syndrome Market Size by Application 6.3.1 North America Metabolic Syndrome Market Size by Application (2016-2021) 6.3.2 North America Metabolic Syndrome Market Size by Application (2022-2027) 6.3.3 North America Metabolic Syndrome Market Size by Application (2016-2027) 6.4 North America Metabolic Syndrome Market Size by Country 6.4.1 North America Metabolic Syndrome Market Size by Country (2016-2021) 6.4.2 North America Metabolic Syndrome Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Metabolic Syndrome Market Size (2016-2027) 7.2 Europe Metabolic Syndrome Market Size by Type 7.2.1 Europe Metabolic Syndrome Market Size by Type (2016-2021) 7.2.2 Europe Metabolic Syndrome Market Size by Type (2022-2027) 7.2.3 Europe Metabolic Syndrome Market Size by Type (2016-2027) 7.3 Europe Metabolic Syndrome Market Size by Application 7.3.1 Europe Metabolic Syndrome Market Size by Application (2016-2021) 7.3.2 Europe Metabolic Syndrome Market Size by Application (2022-2027) 7.3.3 Europe Metabolic Syndrome Market Size by Application (2016-2027) 7.4 Europe Metabolic Syndrome Market Size by Country 7.4.1 Europe Metabolic Syndrome Market Size by Country (2016-2021) 7.4.2 Europe Metabolic Syndrome Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Metabolic Syndrome Market Size (2016-2027) 8.2 Asia-Pacific Metabolic Syndrome Market Size by Type 8.2.1 Asia-Pacific Metabolic Syndrome Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Metabolic Syndrome Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Metabolic Syndrome Market Size by Type (2016-2027) 8.3 Asia-Pacific Metabolic Syndrome Market Size by Application 8.3.1 Asia-Pacific Metabolic Syndrome Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Metabolic Syndrome Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Metabolic Syndrome Market Size by Application (2016-2027) 8.4 Asia-Pacific Metabolic Syndrome Market Size by Region 8.4.1 Asia-Pacific Metabolic Syndrome Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Metabolic Syndrome Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Metabolic Syndrome Market Size (2016-2027) 9.2 Latin America Metabolic Syndrome Market Size by Type 9.2.1 Latin America Metabolic Syndrome Market Size by Type (2016-2021) 9.2.2 Latin America Metabolic Syndrome Market Size by Type (2022-2027) 9.2.3 Latin America Metabolic Syndrome Market Size by Type (2016-2027) 9.3 Latin America Metabolic Syndrome Market Size by Application 9.3.1 Latin America Metabolic Syndrome Market Size by Application (2016-2021) 9.3.2 Latin America Metabolic Syndrome Market Size by Application (2022-2027) 9.3.3 Latin America Metabolic Syndrome Market Size by Application (2016-2027) 9.4 Latin America Metabolic Syndrome Market Size by Country 9.4.1 Latin America Metabolic Syndrome Market Size by Country (2016-2021) 9.4.2 Latin America Metabolic Syndrome Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Metabolic Syndrome Market Size (2016-2027) 10.2 Middle East & Africa Metabolic Syndrome Market Size by Type 10.2.1 Middle East & Africa Metabolic Syndrome Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Metabolic Syndrome Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Metabolic Syndrome Market Size by Type (2016-2027) 10.3 Middle East & Africa Metabolic Syndrome Market Size by Application 10.3.1 Middle East & Africa Metabolic Syndrome Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Metabolic Syndrome Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Metabolic Syndrome Market Size by Application (2016-2027) 10.4 Middle East & Africa Metabolic Syndrome Market Size by Country 10.4.1 Middle East & Africa Metabolic Syndrome Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Metabolic Syndrome Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novo Nordisk 11.1.1 Novo Nordisk Company Details 11.1.2 Novo Nordisk Business Overview 11.1.3 Novo Nordisk Metabolic Syndrome Introduction 11.1.4 Novo Nordisk Revenue in Metabolic Syndrome Business (2016-2021) 11.1.5 Novo Nordisk Recent Development 11.2 Sanofi 11.2.1 Sanofi Company Details 11.2.2 Sanofi Business Overview 11.2.3 Sanofi Metabolic Syndrome Introduction 11.2.4 Sanofi Revenue in Metabolic Syndrome Business (2016-2021) 11.2.5 Sanofi Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Metabolic Syndrome Introduction 11.3.4 Merck Revenue in Metabolic Syndrome Business (2016-2021) 11.3.5 Merck Recent Development 11.4 AstraZeneca 11.4.1 AstraZeneca Company Details 11.4.2 AstraZeneca Business Overview 11.4.3 AstraZeneca Metabolic Syndrome Introduction 11.4.4 AstraZeneca Revenue in Metabolic Syndrome Business (2016-2021) 11.4.5 AstraZeneca Recent Development 11.5 Eli Lily 11.5.1 Eli Lily Company Details 11.5.2 Eli Lily Business Overview 11.5.3 Eli Lily Metabolic Syndrome Introduction 11.5.4 Eli Lily Revenue in Metabolic Syndrome Business (2016-2021) 11.5.5 Eli Lily Recent Development 11.6 AbbVie 11.6.1 AbbVie Company Details 11.6.2 AbbVie Business Overview 11.6.3 AbbVie Metabolic Syndrome Introduction 11.6.4 AbbVie Revenue in Metabolic Syndrome Business (2016-2021) 11.6.5 AbbVie Recent Development 11.7 Actelion Pharmaceuticals 11.7.1 Actelion Pharmaceuticals Company Details 11.7.2 Actelion Pharmaceuticals Business Overview 11.7.3 Actelion Pharmaceuticals Metabolic Syndrome Introduction 11.7.4 Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2016-2021) 11.7.5 Actelion Pharmaceuticals Recent Development 11.8 Adocia 11.8.1 Adocia Company Details 11.8.2 Adocia Business Overview 11.8.3 Adocia Metabolic Syndrome Introduction 11.8.4 Adocia Revenue in Metabolic Syndrome Business (2016-2021) 11.8.5 Adocia Recent Development 11.9 Aegerion Pharmaceuticals 11.9.1 Aegerion Pharmaceuticals Company Details 11.9.2 Aegerion Pharmaceuticals Business Overview 11.9.3 Aegerion Pharmaceuticals Metabolic Syndrome Introduction 11.9.4 Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2016-2021) 11.9.5 Aegerion Pharmaceuticals Recent Development 11.10 Akros Pharma 11.10.1 Akros Pharma Company Details 11.10.2 Akros Pharma Business Overview 11.10.3 Akros Pharma Metabolic Syndrome Introduction 11.10.4 Akros Pharma Revenue in Metabolic Syndrome Business (2016-2021) 11.10.5 Akros Pharma Recent Development 11.11 Alnylam Pharmaceuticals 11.11.1 Alnylam Pharmaceuticals Company Details 11.11.2 Alnylam Pharmaceuticals Business Overview 11.11.3 Alnylam Pharmaceuticals Metabolic Syndrome Introduction 11.11.4 Alnylam Pharmaceuticals Revenue in Metabolic Syndrome Business (2016-2021) 11.11.5 Alnylam Pharmaceuticals Recent Development 11.12 Amarin 11.12.1 Amarin Company Details 11.12.2 Amarin Business Overview 11.12.3 Amarin Metabolic Syndrome Introduction 11.12.4 Amarin Revenue in Metabolic Syndrome Business (2016-2021) 11.12.5 Amarin Recent Development 11.13 nAmgen 11.13.1 nAmgen Company Details 11.13.2 nAmgen Business Overview 11.13.3 nAmgen Metabolic Syndrome Introduction 11.13.4 nAmgen Revenue in Metabolic Syndrome Business (2016-2021) 11.13.5 nAmgen Recent Development 11.14 Amicus Therapeutics 11.14.1 Amicus Therapeutics Company Details 11.14.2 Amicus Therapeutics Business Overview 11.14.3 Amicus Therapeutics Metabolic Syndrome Introduction 11.14.4 Amicus Therapeutics Revenue in Metabolic Syndrome Business (2016-2021) 11.14.5 Amicus Therapeutics Recent Development 11.15 Arbutus Biopharma 11.15.1 Arbutus Biopharma Company Details 11.15.2 Arbutus Biopharma Business Overview 11.15.3 Arbutus Biopharma Metabolic Syndrome Introduction 11.15.4 Arbutus Biopharma Revenue in Metabolic Syndrome Business (2016-2021) 11.15.5 Arbutus Biopharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Metabolic Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Diabetes Table 3. Key Players of Obesity Table 4. Key Players of Hypercholesterolemia Table 5. Key Players of Lysosomal storage diseases Table 6. Global Metabolic Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Metabolic Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Metabolic Syndrome Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Metabolic Syndrome Market Share by Regions (2016-2021) Table 10. Global Metabolic Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Metabolic Syndrome Market Share by Regions (2022-2027) Table 12. Metabolic Syndrome Market Trends Table 13. Metabolic Syndrome Market Drivers Table 14. Metabolic Syndrome Market Challenges Table 15. Metabolic Syndrome Market Restraints Table 16. Global Metabolic Syndrome Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Metabolic Syndrome Market Share by Players (2016-2021) Table 18. Global Top Metabolic Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Syndrome as of 2020) Table 19. Ranking of Global Top Metabolic Syndrome Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Metabolic Syndrome Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Metabolic Syndrome Product Solution and Service Table 23. Date of Enter into Metabolic Syndrome Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Metabolic Syndrome Market Size by Type (2016-2021) (US$ Million) Table 26. Global Metabolic Syndrome Revenue Market Share by Type (2016-2021) Table 27. Global Metabolic Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Metabolic Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Metabolic Syndrome Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Metabolic Syndrome Revenue Market Share by Application (2016-2021) Table 31. Global Metabolic Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Metabolic Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Metabolic Syndrome Market Size by Type (2016-2021) (US$ Million) Table 34. North America Metabolic Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Metabolic Syndrome Market Size by Application (2016-2021) (US$ Million) Table 36. North America Metabolic Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Metabolic Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Metabolic Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Metabolic Syndrome Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Metabolic Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Metabolic Syndrome Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Metabolic Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Metabolic Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Metabolic Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Metabolic Syndrome Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Metabolic Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Metabolic Syndrome Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Metabolic Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Metabolic Syndrome Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Metabolic Syndrome Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Metabolic Syndrome Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Metabolic Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Metabolic Syndrome Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Metabolic Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Metabolic Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Metabolic Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Metabolic Syndrome Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Metabolic Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Metabolic Syndrome Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Metabolic Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Metabolic Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Metabolic Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 63. Novo Nordisk Company Details Table 64. Novo Nordisk Business Overview Table 65. Novo Nordisk Metabolic Syndrome Product Table 66. Novo Nordisk Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 67. Novo Nordisk Recent Development Table 68. Sanofi Company Details Table 69. Sanofi Business Overview Table 70. Sanofi Metabolic Syndrome Product Table 71. Sanofi Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 72. Sanofi Recent Development Table 73. Merck Company Details Table 74. Merck Business Overview Table 75. Merck Metabolic Syndrome Product Table 76. Merck Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 77. Merck Recent Development Table 78. AstraZeneca Company Details Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Metabolic Syndrome Product Table 81. AstraZeneca Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 82. AstraZeneca Recent Development Table 83. Eli Lily Company Details Table 84. Eli Lily Business Overview Table 85. Eli Lily Metabolic Syndrome Product Table 86. Eli Lily Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 87. Eli Lily Recent Development Table 88. AbbVie Company Details Table 89. AbbVie Business Overview Table 90. AbbVie Metabolic Syndrome Product Table 91. AbbVie Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 92. AbbVie Recent Development Table 93. Actelion Pharmaceuticals Company Details Table 94. Actelion Pharmaceuticals Business Overview Table 95. Actelion Pharmaceuticals Metabolic Syndrome Product Table 96. Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 97. Actelion Pharmaceuticals Recent Development Table 98. Adocia Company Details Table 99. Adocia Business Overview Table 100. Adocia Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 101. Adocia Recent Development Table 102. Aegerion Pharmaceuticals Company Details Table 103. Aegerion Pharmaceuticals Business Overview Table 104. Aegerion Pharmaceuticals Metabolic Syndrome Product Table 105. Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 106. Aegerion Pharmaceuticals Recent Development Table 107. Akros Pharma Company Details Table 108. Akros Pharma Business Overview Table 109. Akros Pharma Metabolic Syndrome Product Table 110. Akros Pharma Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 111. Akros Pharma Recent Development Table 112. Alnylam Pharmaceuticals Company Details Table 113. Alnylam Pharmaceuticals Business Overview Table 114. Alnylam Pharmaceuticals Metabolic Syndrome Product Table 115. Alnylam Pharmaceuticals Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 116. Alnylam Pharmaceuticals Recent Development Table 117. Amarin Company Details Table 118. Amarin Business Overview Table 119. Amarin Metabolic Syndrome Product Table 120. Amarin Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 121. Amarin Recent Development Table 122. nAmgen Company Details Table 123. nAmgen Business Overview Table 124. nAmgen Metabolic Syndrome Product Table 125. nAmgen Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 126. nAmgen Recent Development Table 127. Amicus Therapeutics Company Details Table 128. Amicus Therapeutics Business Overview Table 129. Amicus Therapeutics Metabolic Syndrome Product Table 130. Amicus Therapeutics Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 131. Amicus Therapeutics Recent Development Table 132. Arbutus Biopharma Company Details Table 133. Arbutus Biopharma Business Overview Table 134. Arbutus Biopharma Metabolic Syndrome Product Table 135. Arbutus Biopharma Revenue in Metabolic Syndrome Business (2016-2021) & (US$ Million) Table 136. Arbutus Biopharma Recent Development Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Global Metabolic Syndrome Market Share by Type: 2020 VS 2027 Figure 2. Diabetes Features Figure 3. Obesity Features Figure 4. Hypercholesterolemia Features Figure 5. Lysosomal storage diseases Features Figure 6. Global Metabolic Syndrome Market Share by Application: 2020 VS 2027 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Others Case Studies Figure 10. Metabolic Syndrome Report Years Considered Figure 11. Global Metabolic Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Metabolic Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Metabolic Syndrome Market Share by Regions: 2020 VS 2027 Figure 14. Global Metabolic Syndrome Market Share by Regions (2022-2027) Figure 15. Global Metabolic Syndrome Market Share by Players in 2020 Figure 16. Global Top Metabolic Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Syndrome as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Metabolic Syndrome Revenue in 2020 Figure 18. Global Metabolic Syndrome Revenue Market Share by Type (2016-2021) Figure 19. Global Metabolic Syndrome Revenue Market Share by Type (2022-2027) Figure 20. North America Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Metabolic Syndrome Market Share by Type (2016-2027) Figure 22. North America Metabolic Syndrome Market Share by Application (2016-2027) Figure 23. North America Metabolic Syndrome Market Share by Country (2016-2027) Figure 24. United States Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Metabolic Syndrome Market Share by Type (2016-2027) Figure 28. Europe Metabolic Syndrome Market Share by Application (2016-2027) Figure 29. Europe Metabolic Syndrome Market Share by Country (2016-2027) Figure 30. Germany Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Metabolic Syndrome Market Share by Type (2016-2027) Figure 38. Asia-Pacific Metabolic Syndrome Market Share by Application (2016-2027) Figure 39. Asia-Pacific Metabolic Syndrome Market Share by Region (2016-2027) Figure 40. China Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Metabolic Syndrome Market Share by Type (2016-2027) Figure 48. Latin America Metabolic Syndrome Market Share by Application (2016-2027) Figure 49. Latin America Metabolic Syndrome Market Share by Country (2016-2027) Figure 50. Mexico Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Metabolic Syndrome Market Share by Type (2016-2027) Figure 54. Middle East & Africa Metabolic Syndrome Market Share by Application (2016-2027) Figure 55. Middle East & Africa Metabolic Syndrome Market Share by Country (2016-2027) Figure 56. Turkey Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Metabolic Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Novo Nordisk Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 60. Sanofi Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 61. Merck Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 62. AstraZeneca Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 63. Eli Lily Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 64. AbbVie Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 65. Actelion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 66. Adocia Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 67. Aegerion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 68. Akros Pharma Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 69. Alnylam Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 70. Amarin Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 71. nAmgen Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 72. Amicus Therapeutics Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 73. Arbutus Biopharma Revenue Growth Rate in Metabolic Syndrome Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Novo Nordisk Sanofi Merck AstraZeneca Eli Lily AbbVie Actelion Pharmaceuticals Adocia Aegerion Pharmaceuticals Akros Pharma Alnylam Pharmaceuticals Amarin nAmgen Amicus Therapeutics Arbutus Biopharma